Please login to the form below

Not currently logged in
Email:
Password:

Spink wins prostate cancer clinic brief

Healthcare PR specialist Spink is appointed by one of the UK's leading prostate cancer treatment centres to raise awareness of its pioneering work

Healthcare PR specialist Spink has been appointed by one of the UK's leading prostate cancer treatment centres to raise awareness of its pioneering work.

The HIFU Clinic, based at the Spire Gatwick Park Hospital in Sussex, has tasked the agency with building its profile amongst men, healthcare professionals and the media.

The clinic was the first UK hospital to use the Ablatherm High Intensity Focused Ultrasound robotic technology to treat prostate cancer. The treatment is minimally invasive and has fewer side effects than any other therapy. 

Spink will begin its 12-month media and stakeholder relations programme by establishing The HIFU Clinic and its consultants as a centre of excellence among the target audiences.

Director Jo Spink said: "Prostate cancer is a massive problem with one man dying of the disease every hour in the UK. We are delighted to be working with two of the UK's leading Urologists and founders of the Clinic to raise awareness of the life-saving benefits of screening, in addition to the treatment offered at the clinic."

Spink also revealed it will increase its services portfolio, expand its client base and move into new sectors. A relaunch with a new digital offering was one of the development plans revealed by the agency for early 2008.

13th December 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics